Detalles de la búsqueda
1.
Treatment of COVID-19-associated ARDS with mesenchymal stromal cells: a multicenter randomized double-blind trial.
Crit Care;
26(1): 48, 2022 02 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-35189925
2.
Is pre-transplant sensitization against angiotensin II type 1 receptor still a risk factor of graft and patient outcome in kidney transplantation in the anti-HLA Luminex era? A retrospective study.
Transpl Int;
30(11): 1150-1160, 2017 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-28686316
3.
De Novo Focal and Segmental Glomerulosclerosis After COVID-19 in a Patient With a Transplanted Kidney From a Donor With a High-risk APOL1 Variant.
Transplantation;
105(1): 206-211, 2021 01 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32852403
4.
Poor Patient and Graft Outcome After Induction Treatment by Antithymocyte Globulin in Recipients of a Kidney Graft After Nonrenal Organ Transplantation.
Transplant Direct;
4(4): e357, 2018 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-29707628
5.
Sialylation of antibodies in kidney recipients with de novo donor specific antibody, with or without antibody mediated rejection.
Hum Immunol;
77(11): 1076-1083, 2016 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-26546874
Resultados
1 -
5
de 5
1
Próxima >
>>